FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1492958342> ?p ?o ?g. }

• W1492958342 endingPage "4566" @default.
• W1492958342 startingPage "4556" @default.
• W1492958342 abstract "We describe the characterization of an antitumor drug resistance following multiple step selection of hamster cells to the 2,4-diaminopyrimidines (DAP) metoprine, pyrimethamine (Pyr), and trimethoprim (Tmp). Pyr and Tmp are DAP lipophilic antifolates currently used as antiparasitic and antibacterial antibiotics, respectively. Dihydrofolate reductase (DHFR) from hamster cells bore a low or poor affinity to these DAP as compared to the hydrophilic folate antagonist methotrexate (MTX). Metoprine-resistant cells over-expressed DHFR enzyme and consequently displayed a high level of resistance to both hydrophilic and lipophilic antifolates including DAP but maintained wild type sensitivity to pleiotropic drugs involved in multi-drug resistance (MDR). In contrast, although Pyr- and Tmp-resistant cells expressed parental levels of wild type DHFR, they displayed a high degree of resistance to DAP and, surprisingly, to the lipophilic MTX analogs piritrexim (PTX) and trimetrexate (TMTX), while maintaining sensitivity to MTX. These drug-resistant cells maintained wild type mRNA levels of the MDR gene product P-glycoprotein and showed collateral hypersensitivity to pleiotropic drugs. To study the underlying mechanism of this apparently new resistance phenotype, we have employed fluorescein-methotrexate (F-MTX) labeling of cells and its displacement by different antifolates. Parental AA8 and Pyr-resistant cells showed a similar level of F-MTX labeling, however, while DAP, TMTX, and PTX showed an efficient competitive displacement of F-MTX from AA8 cells, Pyr-resistant cells displayed a persistent retention of F-MTX labeling in the presence of high concentrations of these lipophilic antifolates. Pyr-resistant cells showed a wild type displacement of F-MTX with MTX. This DAP resistance phenotype was unstable as it was rapidly lost upon growth under nonselective conditions. Furthermore, when the antifolate resistance levels of Pyr-resistant cells were plotted versus the ratios of the 50% F-MTX displacement values obtained with resistant and parental AA8 cells, a good correlation (r2 > 0.98) was obtained. We conclude that Pyr-resistant cells possess a novel phenotype that derives its resistance to lipophilic antifolates solely from a predominant decrease in the accumulation of DAP and lipid-soluble analogs of MTX." @default.
• W1492958342 created "2016-06-24" @default.
• W1492958342 creator A5013852274 @default.
• W1492958342 creator A5081749661 @default.
• W1492958342 date "1993-02-01" @default.
• W1492958342 modified "2023-09-29" @default.
• W1492958342 title "Characterization of a lipophilic antifolate resistance provoked by treatment of mammalian cells with the antiparasitic agent pyrimethamine." @default.
• W1492958342 cites W1485133218 @default.
• W1492958342 cites W1492282552 @default.
• W1492958342 cites W1507212424 @default.
• W1492958342 cites W1551286813 @default.
• W1492958342 cites W1560690111 @default.
• W1492958342 cites W195608166 @default.
• W1492958342 cites W1969332794 @default.
• W1492958342 cites W1975761685 @default.
• W1492958342 cites W1978512571 @default.
• W1492958342 cites W2014669590 @default.
• W1492958342 cites W2018033770 @default.
• W1492958342 cites W2030879518 @default.
• W1492958342 cites W2033798598 @default.
• W1492958342 cites W2035038624 @default.
• W1492958342 cites W2038325709 @default.
• W1492958342 cites W2040053387 @default.
• W1492958342 cites W2045824142 @default.
• W1492958342 cites W2049447350 @default.
• W1492958342 cites W2049772927 @default.
• W1492958342 cites W2051586659 @default.
• W1492958342 cites W2056664493 @default.
• W1492958342 cites W2097878215 @default.
• W1492958342 cites W2112655151 @default.
• W1492958342 cites W2125413385 @default.
• W1492958342 cites W2158292139 @default.
• W1492958342 cites W2271920406 @default.
• W1492958342 cites W259072379 @default.
• W1492958342 cites W35929032 @default.
• W1492958342 cites W4293247451 @default.
• W1492958342 doi "https://doi.org/10.1016/s0021-9258(18)53646-2" @default.
• W1492958342 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8440739" @default.
• W1492958342 hasPublicationYear "1993" @default.
• W1492958342 type Work @default.
• W1492958342 sameAs 1492958342 @default.
• W1492958342 citedByCount "23" @default.
• W1492958342 countsByYear W14929583422012 @default.
• W1492958342 countsByYear W14929583422013 @default.
• W1492958342 countsByYear W14929583422021 @default.
• W1492958342 countsByYear W14929583422022 @default.
• W1492958342 crossrefType "journal-article" @default.
• W1492958342 hasAuthorship W1492958342A5013852274 @default.
• W1492958342 hasAuthorship W1492958342A5081749661 @default.
• W1492958342 hasBestOaLocation W14929583421 @default.
• W1492958342 hasConcept C114851261 @default.
• W1492958342 hasConcept C142724271 @default.
• W1492958342 hasConcept C185592680 @default.
• W1492958342 hasConcept C203014093 @default.
• W1492958342 hasConcept C2777035104 @default.
• W1492958342 hasConcept C2778048844 @default.
• W1492958342 hasConcept C2778371730 @default.
• W1492958342 hasConcept C2778397455 @default.
• W1492958342 hasConcept C2781059491 @default.
• W1492958342 hasConcept C2781382166 @default.
• W1492958342 hasConcept C2781421772 @default.
• W1492958342 hasConcept C2911037157 @default.
• W1492958342 hasConcept C71924100 @default.
• W1492958342 hasConcept C86803240 @default.
• W1492958342 hasConcept C89423630 @default.
• W1492958342 hasConcept C98274493 @default.
• W1492958342 hasConceptScore W1492958342C114851261 @default.
• W1492958342 hasConceptScore W1492958342C142724271 @default.
• W1492958342 hasConceptScore W1492958342C185592680 @default.
• W1492958342 hasConceptScore W1492958342C203014093 @default.
• W1492958342 hasConceptScore W1492958342C2777035104 @default.
• W1492958342 hasConceptScore W1492958342C2778048844 @default.
• W1492958342 hasConceptScore W1492958342C2778371730 @default.
• W1492958342 hasConceptScore W1492958342C2778397455 @default.
• W1492958342 hasConceptScore W1492958342C2781059491 @default.
• W1492958342 hasConceptScore W1492958342C2781382166 @default.
• W1492958342 hasConceptScore W1492958342C2781421772 @default.
• W1492958342 hasConceptScore W1492958342C2911037157 @default.
• W1492958342 hasConceptScore W1492958342C71924100 @default.
• W1492958342 hasConceptScore W1492958342C86803240 @default.
• W1492958342 hasConceptScore W1492958342C89423630 @default.
• W1492958342 hasConceptScore W1492958342C98274493 @default.
• W1492958342 hasIssue "6" @default.
• W1492958342 hasLocation W14929583421 @default.
• W1492958342 hasOpenAccess W1492958342 @default.
• W1492958342 hasPrimaryLocation W14929583421 @default.
• W1492958342 hasRelatedWork W1492958342 @default.
• W1492958342 hasRelatedWork W1964813475 @default.
• W1492958342 hasRelatedWork W1980780826 @default.
• W1492958342 hasRelatedWork W2038277928 @default.
• W1492958342 hasRelatedWork W2054212305 @default.
• W1492958342 hasRelatedWork W2088791835 @default.
• W1492958342 hasRelatedWork W2274340428 @default.
• W1492958342 hasRelatedWork W2986971017 @default.
• W1492958342 hasRelatedWork W4253535579 @default.
• W1492958342 hasRelatedWork W4365505168 @default.
• W1492958342 hasVolume "268" @default.
• W1492958342 isParatext "false" @default.

• next